Characterization of Lymphotoxin-αβ Complexes on the Surface of Mouse Lymphocytes

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3288-3298

  Browning, Jeffrey L ^a   Sizing, Irene Dougas ^a   Lawton, Pornsri ^a   Bourdon, Paul R ^a   Rennert, Paul D ^a   Majeau, Gerard R ^a   Ambrose, Christine M ^a   Hession, Catherine ^a   Miatkowski, Konrad ^a   Griffiths, David A ^a   Ngam ek, Apinya ^a   Meier, Werner ^a   Benjamin, Christopher D ^a   Hochman, Paula S ^a  

^a BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN; LTB PROTEIN, HUMAN; LTB PROTEIN, MOUSE; LTB PROTEIN, RAT; LYMPHOTOXIN; LYMPHOTOXIN BETA; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; FLOW CYTOMETRY; GENETICS; HUMAN; HYBRIDOMA; IMMUNOLOGY; LYMPHOCYTE; MACROPHAGE; METABOLISM; MOUSE; RAT; SOLUBILITY; SPECIES DIFFERENCE; T CELL LYMPHOMA; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CELL LINE; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; IMMUNOGLOBULINS; LYMPHOCYTES; LYMPHOMA, T-CELL; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MACROPHAGES; MEMBRANE PROTEINS; MICE; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SOLUBILITY; SPECIES SPECIFICITY; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031252310     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
2. Gruss, H. J., and S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85:3378.
3. Ware, C. F., T. L. VanArsdale, P. D. Crowe, and J. L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175.
4. Browning, J. L., A. Ngam-ek, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hession, G. B. O'Brine, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847.
5. Mapara, M. Y., R. C. Bargou, C. Beck, B. Heilig, B. Dorken, and G. Moldenhauer. 1994. Lymphotoxin-alpha/beta heterodimer is expressed on leukemic hairy cells and activated human B lymphocytes. Int. J. Cancer 58:248.
6. Browning, J. L. I. Dougas, A. Ngam-ek, P. R. Bourdon, B N. Ehrenfels, K. Miatkowski, M. Zafari, A. M. Yampaglia, P. Lawton, W. Meier, C. P. Benjamin, and C. Hession. 1995. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33.
7. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-beta-specilic receptor. Science 264:707.
8. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
9. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-alpha-deficient mice: effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685.
10. Eugster, H.-P., M. Mueller, U. Karrer, B. D. Car, B. Schnyder, V. M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, R. Zinkernagel, H. Bluethmann, and B. Ryffel. 1996. Multiple abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int. Immunol. 8:23.
11. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177:1575.
12. Kinkhabwala, M., P. Sehajpa, E. Skolnik, D. Smith, V. K. Sharma, H. Vlassara, A. Cerami, and M. Suthanthiran. 1990. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J. Exp. Med. 171:941.
13. Cseh, K., and B. Beutler. 1989. Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein. J. Biol. Chem. 264:16256.
14. Lopez, C. M., S. J. Garcia, L. Herbert, R. Riley, M. E. Handel, E. R. Podack, and D. M. Lopez. 1994. Soluble and membrane-bound TNF-α are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets. J. Immunol. 152:3333.
15. Li, C. B., P. W. Gray, P. F. Lin, K. M. McGrath, F. H. Ruddle, and N. H. Ruddle. 1987. Cloning and expression of murine lymphotoxin cDNA. J. Immunol. 138: 4496.
16. Lawton, P., J. Nelson, R. Tizard, and J. L. Browning. 1995. Characterization of the mouse lymphotoxin-beta gene. J. Immunol. 154:239.
17. Pokholok, D. K., I. G. Maroulakou, D. V. Kuprash, M. B. Alimzhanov, S. V. Kozlov, T. I. Novobrantseva, R. L. Turetskaya, J. E. Green, and S. A. Nedospasov. 1995. Cloning and expression analysis of the murine lymphotoxin beta gene. Proc. Natl. Acad. Sci. USA 92:674.
18. Laskov, R., G. Lancz, N. H. Ruddle, K. M. McGrath, S. Specter, T. Klein, J. Y. Djeu, and H. Friedman. 1990. Production of tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) by murine pre-B and B cell lymphomas. J. Immunol. 144:3424.
19. Millet, I., and N. H. Ruddle. 1994. Differential regulation of lymphotoxin (LT), lymphotoxin-β (LT-β), and TNF-α in murine T cell clones activated through the TCR. J. Immunol. 152:4336.
20. Weil, D., and F. Dautry. 1988. Induction of tumor necrosis factor-alpha and -beta and interferon-gamma mRNA by interleukin 2 in murine lymphocytic cell lines. Oncogene Res. 3:409.
21. Sheehan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize tumor necrosis factors. J. Immunol. 142:3884.
22. Powell, M. B., D. Mitchell, J. Lederman, J. Buckmeier, S. S. Zamvil, M. Graham, N. H. Ruddle, and L. Steinman. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:539.
23. Paul, N. L., and N. H. Ruddle. 1988. Lymphotoxin. Annu. Rev. Immunol. 6:407.
24. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and ihe type I TNF receptor in the formation of germinal centers. Science 271:1289.
25. Matsumoto, M., S. F. Lo, C. J. L. Carruthers, J. Min, S. Mariathasan, G. Huang, D. R. Plas, S. M. Martin, R. S. Geha, M. H. Nahm, and D. D. Chaplin. 1996. Affinity maturation without germinal centres in lymphotoxin-α deficient mice. Nature 382:462.
26. Rennert, P. D., J. L. Browning, R. Mebius, F. Mackay, and P. S. Hochman. 1996. Surface lymphotoxin alpha/beta complex is required for the development for peripheral lymphoid organs. J. Exp. Med. 184:1999.
27. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin-beta deficient mice. Immunity 6:491.
28. Mackay, F., G. R. Majeau, P. Lawton, P. S. Hochman, and J. L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033.
29. Kratz, A., A. Campos-Neto, M. S. Hanson, and N. H. Ruddle. 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183: 1461.
30. Huff, T. F., T. Uede, and K. Ishizaka. 1982. Formation of rat IgE-binding factors by rat-mouse T cell hybridomas. J. Immunol. 129:509.
31. Jardieu, P., T. Uede, and K. Ishizaka. 1985. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation. J. Immunol. 135:922.
32. Force, W. R., B. N. Walter, C. Hession, R. Tizard, C. A. Kozak, J. L. Browning, and C. F. Ware 1995. Mouse lymphotoxin-beta receptor: molecular genetics, ligand binding, and expression. J. Immunol. 155:5280.
33. Majeau, G. R., W. Meier, B. Jimmo, D. Kioussis, and P. S. Hochman. 1994. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses: structure/function analysis in vitro and in human CD2 transgenic mice. J. Immunol. 152:2753.
34. Browning, J. L., K. Miatkowski, I. Sizing, D. A. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin-beta receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867.
35. Ling, L. E., M. Zafari, D. Reardon, M. Brickelmeier, S. E. Goelz, and C. D. Benjamin 1995. Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein. J. Interferon Cytokine Res. 15:55.
36. English, B. K., W. M. Weaver, and C. B. Wilson. 1991. Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes. J. Biol. Chem. 266:7108.
37. Browning, J. L., K. Miatkowski, D. A. Griffiths, P. R. Bourdon, C. Hession, C. M. Ambrose, and W. Meier. 1996. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta. J. Biol. Chem. 271:8618.
38. 37a. Mackay, P., P. R. Bourdon, D. A. Griffiths, P. Lawton, M. Zafari, I. D. Sizing, K. Miatkowski, A. Ngam-ek, C. D. Benjamin, C. Hession, C. M. Ambrose, W. Meier, and J. L. Browning. 1997. Cytotoxic activities of recombinant soluble murine lymphotoxin-α and lymphotoxin-αβ complexes. J. Immunol. In press this issue.
39. Ruddle, N. H., C. M. Bergman, K. M. McGrath, E. G. Lingenheld, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
40. Yang, X. D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995.
41. Bringman, T. S., and B. B. Aggarwal. 1987. Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays and as structural probes. Hybridoma 6:489.
42. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:3881.
43. Lopez-Cabrera, M., E. Munoz, M. V. Blazquez, M. A. Ursa, A. G. Santis, and F. Sanchez-Madrid. 1995. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J. Biol. Chem. 270: 21545.
44. Worm, M., and R. S. Geha. 1994. CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int. Immunol. 6:1883.
45. Hochman, P. S., G. R. Majeau, F. Mackay, and J. L. Browning. 1996. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J. Inflammation 46:220.
46. Mackay, F., G. R. Majeau, P. S. Hochman, and J. L. Browning. 1996. Lymphotoxin-β receptor triggering induces the activation of NF-κB transcription factor in some cell types. J. Biol. Chem. 271:24934.
47. Abe, Y., A. Horiuchi, Y. Osuka, S. Kimura, G. A. Granger, and T. Gatanaga. 1992. Studies of membrane-associated and soluble (secreted) lymphotoxin in human lymphokine-activated T-killer cells in vitro. Lymphokine Cytokine Res. 11:115.
48. + human cytotoxic T-cell clones. Blood 81:1527.
49. Trueb, R., C. van Huffel, A. Poltorak, M. Valdex-Silva, and B. Beutler. 1995. Expression of an adenovirally encoded lymphotoxin-β inhibitor prevents clearance of listeria monocytogenes in mice. J. Inflammation 45:239.
50. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
51. Matsumoto, M., Y.-X. Fu, H. Molina, and D. D. Chaplin 1997. Lymphotoxin-α-deficient mice and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137.
52. + T cell clones: role for membrane TNF-α/TNF-α receptors and CD2/CD58 interactions. J. Immunol. 153:4872.
53. Grell, M., E. Douni, H. Wajant, M. Loehden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.